| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |